Covid-19: Should intellectual property rights be challenged?

This policy brief highlights the value of intellectual property pooling instruments such as the Medicines Patent Pool for the management of the Covid-19 health crisis by the international community. As an alternative between the suspension of intellectual property and bilateral cooperation agreements between firms, patent pools present advantages for both public health and the pharmaceutical industry alike.